The startup utilizes immunometabolism to develop targeted cancer therapies that enhance the immune system's ability to recognize and attack tumor cells. This approach addresses the limitations of traditional cancer treatments by improving efficacy and reducing side effects through a more precise modulation of metabolic pathways in immune cells.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cancer treatments often fail to fully eradicate tumors and can cause significant side effects due to their lack of specificity. The immune system's ability to recognize and eliminate cancer cells is often suppressed within the tumor microenvironment, limiting the effectiveness of immunotherapies.
Solution
This startup is developing targeted cancer therapies based on immunometabolism, an approach that aims to enhance the immune system's ability to recognize and attack tumor cells by modulating metabolic pathways in immune cells. By precisely targeting these metabolic pathways, the therapies aim to improve the efficacy of cancer treatment while reducing the associated side effects. The company's approach seeks to overcome the limitations of conventional cancer treatments and unlock the full potential of the immune system in fighting cancer. This involves identifying and targeting key metabolic vulnerabilities within immune cells to boost their anti-tumor activity and promote a more robust and sustained immune response against cancer. The therapies are designed to reprogram the tumor microenvironment, making it more conducive to immune cell infiltration and activation, ultimately leading to improved tumor control and patient outcomes.
Target Audience
The primary target audience includes oncology researchers, clinicians, and pharmaceutical companies focused on developing novel cancer immunotherapies with improved efficacy and reduced toxicity.
Features
- Modulation of metabolic pathways in immune cells to enhance their anti-tumor activity
- Targeted approach to improve efficacy and reduce side effects compared to traditional treatments
- Reprogramming the tumor microenvironment to promote immune cell infiltration and activation
- Identification and targeting of key metabolic vulnerabilities within immune cells
- Development of innovative medicines, diagnostics, and healthcare treatments